These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17224754)

  • 21. Frequency doubling technology perimetry in normal children.
    Quinn LM; Gardiner SK; Wheeler DT; Newkirk M; Johnson CA
    Am J Ophthalmol; 2006 Dec; 142(6):983-9. PubMed ID: 17046702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reliability of frequency-doubling technology (FDT) perimetry in a pediatric population.
    Becker K; Semes L
    Optometry; 2003 Mar; 74(3):173-9. PubMed ID: 12645850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of test reliability on the screening performance of frequency-doubling perimetry.
    Heeg GP; Jansonius NM
    Am J Ophthalmol; 2006 Mar; 141(3):585-7. PubMed ID: 16490521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of test duration as a screening criterion for frequency doubling perimetry.
    Thomas R; Parikh R; Muliyil J; Bhat S; George R
    Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography.
    Robin TA; Müller A; Rait J; Keeffe JE; Taylor HR; Mukesh BN
    Ophthalmic Epidemiol; 2005 Jun; 12(3):167-78. PubMed ID: 16036475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency doubling perimetry and short-wavelength automated perimetry to detect early glaucoma.
    Leeprechanon N; Giaconi JA; Manassakorn A; Hoffman D; Caprioli J
    Ophthalmology; 2007 May; 114(5):931-7. PubMed ID: 17397926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the high specificity Screening Program (C-20-1) of the Frequency Doubling Technology (FDT) perimeter in clinical practice.
    North RV; Jones AL; Hunter E; Morgan JE; Wild JM
    Eye (Lond); 2006 Jun; 20(6):681-7. PubMed ID: 15999135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for improving the diagnostic specificity of the frequency doubling perimeter.
    Heeg GP; Stoutenbeek R; Jansonius NM
    Acta Ophthalmol Scand; 2005 Feb; 83(1):53-6. PubMed ID: 15715557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of combined GDx-VCC and matrix FDT in a glaucoma screening trial.
    Tóth M; Kóthy P; Vargha P; Holló G
    J Glaucoma; 2007 Aug; 16(5):462-70. PubMed ID: 17700289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of screening for open-angle glaucoma in high-risk populations with single-test screening mode frequency doubling technology perimetry (FDT).
    Kamdeu Fansi AA; Li G; Harasymowycz PJ
    J Glaucoma; 2011 Mar; 20(3):167-71. PubMed ID: 20436361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency doubling perimetry screening mode compared to the full-threshold mode.
    Stoutenbeek R; Heeg GP; Jansonius NM
    Ophthalmic Physiol Opt; 2004 Nov; 24(6):493-7. PubMed ID: 15491476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The methodology of visual field testing with frequency doubling technology in the National Health and Nutrition Examination Survey, 2005-2006.
    Terry AL; Paulose-Ram R; Tilert TJ; Johnson CA; Zhang X; Lee PP; Saaddine JB
    Ophthalmic Epidemiol; 2010 Dec; 17(6):411-21. PubMed ID: 21090914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of efficient threshold strategies for frequency doubling technology perimetry using computer simulation.
    Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):322-31. PubMed ID: 11818373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reliability of frequency-doubling perimetry in young children.
    Blumenthal EZ; Haddad A; Horani A; Anteby I
    Ophthalmology; 2004 Mar; 111(3):435-9. PubMed ID: 15019315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Frequency-Doubling Technology Perimetry as a Means of Screening for Glaucoma and Other Eye Diseases Using the National Health and Nutrition Examination Survey.
    Boland MV; Gupta P; Ko F; Zhao D; Guallar E; Friedman DS
    JAMA Ophthalmol; 2016 Jan; 134(1):57-62. PubMed ID: 26562502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for glaucoma with frequency-doubling technology and Damato campimetry.
    Yamada N; Chen PP; Mills RP; Leen MM; Lieberman MF; Stamper RL; Stanford DC
    Arch Ophthalmol; 1999 Nov; 117(11):1479-84. PubMed ID: 10565516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.